← All trials
NCT01570504
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2013
- Primary completion
- May 30, 2018
- Completion date
- May 30, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 312
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Centro per le Malattie TropicaliLead sponsor
- University of VeronaOverall official - principal investigator
- European CommissionCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.